Presented by: Lisa A. Marsch, PhD
Digital therapeutics–software used to prevent, treat, or manage a medical disorder or disease–are redefining the future of healthcare. Digital therapeutics package an entire model of care that can be delivered with fidelity and in accordance with state-of-the-science best practices into a unified, seamless digital delivery system. Digital therapeutics have been particularly transformative in the field of substance use, mental health, and other behavioral health conditions and can markedly improve access to care, quality of care, and treatment outcomes, while reducing costs, for a wide array of audiences in diverse settings. In this presentation, Dr. Lisa A. Marsch (Dartmouth Center for Technology and Behavioral Health) will review the state of the science of digital therapeutics for behavioral health and timely opportunities to scale up access to these digital health tools via multiple paths to deployment around the world.
Sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network.
1.5 CME/CE available to all those who attend the live event. Please specify the type of credit you want below. For accreditation information, see https://adai.uw.edu/nwattc/pdfs/webinar-202302.pdf